Comma Raises $2M Seed Round to Bring Personalized Science to Reproductive Health
The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/...
Pregnancy
New Survey from Aeroflow Urology Reveals Lack of Postpartum Incontinence Care Causes Lasting Health Problems for Mothers
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and...
Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February
BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...
Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices
Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June 2024ATLANTA, Feb. 04, 2025...
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety...
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety...
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference
Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc....
Women’s Health research Collaborative and Avana Health Launch Joint Initiative Around Acute Heavy Menstrual Bleeding Care
NASHVILLE, Tenn., Jan. 28, 2025 /PRNewswire/ -- The Women's Health research Collaborative (WHrC), a Petauri Kinect network of excellence, and...
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planningNEW YORK,...
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with...
Sera Prognostics to Host Virtual R&D Day on January 31
Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY, Jan. 27, 2025...
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
Conference call and webcast scheduled to take place on Wednesday, February 5, 2025, at 4:30 p.m. E.T.SCOTTSDALE, Ariz., Jan. 23,...
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
deCODE genetics: Complete recombination map of the human-genome, a major step in genetics
REYKJAVIK, Iceland, Jan. 22, 2025 /PRNewswire/ -- Complete recombination map of the human-genome, a major step in genetics Scientists at...
Emily Oster’s ParentData Launches 2025 Edition of Weekly Pregnancy Guide
PROVIDENCE, R.I., Jan. 22, 2025 /PRNewswire/ -- ParentData, the data-driven guide through pregnancy, parenthood, and beyond, has announced the relaunch of...
Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiny Health, a leader in at-home gut microbiome testing, today announced the...
Glooko Secures Reimbursement for Remote Monitoring of Gestational Diabetes in France
PALO ALTO, Calif., Jan. 21, 2025 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and...
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE...